GO
Loading...

Enter multiple symbols separated by commas

Takeover Bids

More

  • Hostess Feeding Frenzy Begins   Thursday, 29 Nov 2012 | 7:27 PM ET
    Hostess Feeding Frenzy Begins

    The focus for Hostess has now turned to selling its assets and its 30 brands, reports CNBC's Kayla Tausche.

  • The Twinkie Lifeline?   Thursday, 29 Nov 2012 | 4:24 PM ET
    Twinkie Looks for a Lifeline?

    Hostess says it is speaking with more than 110 parties that are interested in buying its brands. CNBC's Kayla Tausche reports.

  • Cyber Monday: Online Retail Winners   Monday, 26 Nov 2012 | 5:15 PM ET
    Cyber Monday: Online Retail Winners

    Is Deckers, the maker of Uggs, Target's next takeover target? The Fast Money traders, weigh in; and Thom Blischok, Booz & Co. chief retail analyst, discusses which retailers are making big moves in mobile and online this holiday season.

  • WSJ: Advanced Micro Not Pursuing Sale   Tuesday, 13 Nov 2012 | 4:53 PM ET
    WSJ: Advanced Micro Not Pursuing Sale

    According to the WSJ, Advanced Micro is not pursuing a sale of its company or significant assets, reports CNBC's Brian Shactman.

  • Faber Report: Sprint Gains Control of Clearwire   Thursday, 18 Oct 2012 | 9:40 AM ET
    Faber Report: Sprint Gains Control of Clearwire

    CNBC's David Faber reports the latest detail on Sprint's takeover of Clearwire; and weighs in on Verizon's earnings.

  • Ellison Eyeing the Lakers?   Friday, 12 Oct 2012 | 4:43 PM ET
    Ellison Eyeing the Lakers?

    CNBC's Robert Frank says Ellison's reported interest in bidding on AEG, which owns a piece of the Lakers, is in very preliminary stages. Mark Martiak, Premier Wealth Management, provides perspective.

  • Ackman: P&G Has Stumbled Over Past Few Years   Tuesday, 2 Oct 2012 | 7:40 AM ET
    Ackman: P&G Has Stumbled Over Past Few Years

    P&G has been one of the great growth companies of all times but quite frankly it has stumbled over the past couple of years under the current CEO's leadership, said William Ackman, Pershing Square Capital Management founder & CEO, discussing the problems at Procter & Gamble.

  • Ackman: P&G 'Stumbled' Under McDonald's Leadership

    In this excerpt from a "Squawk Box" interview on October 2, 2012, Pershing Square's Bill Ackman said he had bought some stock and expressed his concerns about the company to its Board.

  • Equity Firms Like Bain Are Depicted as Colluding Wednesday, 12 Sep 2012 | 10:01 AM ET
    Bain Capital headquarters, Bostonb Mass.

    In court documents that lawyers for Bain Capital sought to keep secret, the company and other leading private equity firms are depicted as unofficial partners in a bid-rigging conspiracy aimed at holding down the prices of businesses they were seeking to buy, The New York Times reports.

  • Finding Value in Health Care Stocks   Monday, 10 Sep 2012 | 8:57 AM ET
    Finding Value in Health Care Stocks

    Dinakar Singh, TPG-Axon Capital CEO, discusses the best way to play the health care space.

  • Short Regional Banks: Singh   Monday, 10 Sep 2012 | 8:41 AM ET
    Short Regional Banks: Singh

    Dinakar Singh, TPG-Axon Capital CEO, discusses the best way to trade financials after the banking crisis.

  • Does QE3 Really Matter?   Monday, 10 Sep 2012 | 8:03 AM ET
    Does QE3 Really Matter?

    "Ultimately, I don't think lower rates make that much difference anymore," says Dinakar Singh, TPG-Axon Capital CEO, sharing his thoughts on additional Fed easing.

  • Featured Speaker - Henry R. Kravis Monday, 16 Jul 2012 | 12:04 PM ET
    Henry R. Kravis, Co-Chairman and Co-CEO, KKR

    The co-founder of the trailblazing private-equity firm Kohlberg Kravis Roberts is actively involved in managing the firm famous for its leveraged buyout of RJR Nabisco 25 years ago.

  • Faber Report: GSK's Acquires Human Genome Science

    CNBC's David Faber reports the latest details on GlaxoSmithKline's takeover bid for Human Genome Science.

  • Five Stocks Ripe for Takeovers? Tuesday, 10 Jul 2012 | 8:49 AM ET
    big_vs_little2_200.jpg

    Here are five companies that could be bought, according to analyst Ken Hackel of CT Capital, best known for his book, “Security Valuation and Risk Analysis.”

  • $7.1 Billion Pharma Deal   Monday, 2 Jul 2012 | 1:11 PM ET
    $7.1 Billion Pharma Deal

    CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.

  • Deal Brewing Between Grupo Modelo and Anheuser   Monday, 25 Jun 2012 | 11:50 AM ET
    Deal Brewing Between Grupo Modelo and Anheuser

    CNBC's Kayla Tausche reports Grupo Modelo has confirmed it is in talks on expanding its relationship with Anheuser-Busch.

  • What's Next for Carl Icahn?   Monday, 30 Apr 2012 | 4:14 PM ET
    What's Next for Carl Icahn?

    CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.

  • Human Genome Rejects GlaxoSmithKline's Bid   Thursday, 19 Apr 2012 | 12:41 PM ET
    Human Genome Rejects GlaxoSmithKline's Bid

    Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.

  • Illumina Plays Offense & Final Trade   Tuesday, 17 Apr 2012 | 12:55 PM ET
    Illumina Plays Offense & Final Trade

    CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.